z-logo
open-access-imgOpen Access
Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: influence of neuraminidase inhibitors
Author(s) -
Miguel DelgadoRodríguez,
Jesús Castilla,
Pere Godoy,
Vicente Martín,
N. Soldevila,
Jordi Alonso,
Jenaro Astray,
Maretva Baricot,
Rafael Cantón,
Ady Castro,
Fernando GónzálezCandelas,
José M. Mayoral,
José M. Quintana,
Tomàs Pumarola,
Sonia Tamames,
Marc Sáez,
Fabiola Domínguez
Publication year - 2012
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dks098
Subject(s) - neuraminidase , medicine , neuraminidase inhibitor , oseltamivir , intensive care , intensive care unit , pandemic , pediatrics , intensive care medicine , covid-19 , virus , immunology , disease , infectious disease (medical specialty)
The H1N1 influenza pandemic strain has been associated with a poor prognosis in hospitalized patients. The present report evaluates the factors influencing prognosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom